Ophthalmology, Retina Specialist · Dublin, OH
NPI
1477644573
Since 2006
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
6655 Post Rd
Dublin, OH, 43016
Phone (614) 339-8500
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
20,605 services
Medicare patients, 2024
668
Average age 76
Drug cost, 2024
$3.7M
2,069 prescriptions
Company payments, 2025
$1,113
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dino D Klisovic was code J2777 (injection, faricimab-svoa, 0.1 mg), 13,140 times for 41 patients. In total Dino D Klisovic billed 20,605 services in 51 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 13,140 | 41 | $27.36 | $360K |
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2,415 | 38 | $116.55 | $281K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,319 | 519 | $30.27 | $40K |
| 67028 Intravitreal Injection | Office | 1,080 | 250 | $86.45 | $93K |
| J0178 Injection, aflibercept, 1 mg | Office | 702 | 85 | $651.70 | $457K |
| 99214 Office E&M - Established | Office | 605 | 353 | $88.04 | $53K |
| J3590 Unclassified biologics | Office | 256 | 89 | $43.32 | $11K |
| J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 238 | 21 | $158.90 | $38K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 216 | 12 | $262.44 | $57K |
| 99204 Office E&M - New | Office | 124 | 124 | $121.30 | $15K |
| 99213 Office E&M - Established | Office | 84 | 82 | $61.27 | $5,146 |
| 99215 Office E&M - Established | Office | 58 | 42 | $130.36 | $7,561 |
| 92250 Angiography | Office | 25 | 25 | $23.86 | $596 |
| 99205 Office E&M - New | Office | 25 | 25 | $167.40 | $4,185 |
| 76512 Ultrasound - Nonspecific | Office | 17 | 14 | $33.03 | $561 |
By year: 2022 $1.1M for 5,898 services; 2023 $1.3M for 15,173 services; 2024 $1.5M for 20,605 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dino D Klisovic prescribed most often to Medicare patients was Timolol Maleate, with 320 prescriptions and refills. In total Dino D Klisovic wrote 2,069 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Timolol Maleate Generic | 320 | 602 | 98 | $2,296 |
| Mycophenolate Mofetil Generic | 209 | 319 | 44 | $22K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 199 | 212 | 128 | $2,318 |
| Valacyclovir Valacyclovir Hcl | 192 | 377 | 57 | $9,969 |
| Latanoprost Generic | 169 | 315 | 53 | $1,307 |
| Brimonidine Tartrate Generic | 131 | 233 | 51 | $1,290 |
| Prednisolone Acetate Generic | 117 | 209 | 72 | $3,332 |
| Atropine Sulfate Generic | 110 | 219 | 98 | $3,201 |
| Erythromycin Erythromycin Base | 67 | 82 | 26 | $918 |
| Prednisone Generic | 53 | 57 | 39 | $306 |
| Dorzolamide Hcl Generic | 46 | 87 | 18 | $662 |
| Doxycycline Hyclate Generic | 42 | 92 | 16 | $1,246 |
| Azathioprine Generic | 40 | 76 | 13 | $1,097 |
| Ketorolac Tromethamine Generic | 36 | 49 | 15 | $1,060 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 32 | 32 | 28 | $134 |
Brand drugs: 336 claims; generic drugs: 1,733 claims; opioid claims: 35.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dino D Klisovic $1,113 ($1,113 in general payments such as food, travel and fees) from 7 companies. The largest payer was Genentech USA, Inc. with $289.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.